Overview

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To investigate safety, tolerability, pharmacokinetics including posology, and pharmacodynamics of multiple rising doses of BI 1021958 in otherwise healthy mild asthmatic subjects
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim